Instrument Inactif

Communiqués TESARO Inc

Actions

US8815691071

Recherche biotechnologique et médicale

Communiqués

04/12/18	TESARO, Inc. Gives Notice of Anticipated Make-Whole Adjustment Event to Holders of Its Convertible Senior Notes	GL
03/12/18	TESARO, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
03/12/18	GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company	GL
28/11/18	TESARO : Advancing Clinical Trials Endeavoring to Improve Odds Against Pancreatic Cancer	PR
26/11/18	Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Tesaro, Inc.	BU
09/11/18	TESARO Announces Immuno-Oncology Data Presentations at SITC 2018 Annual Meeting	GL
30/10/18	The Foundation for Women’s Cancer and TESARO Partner on the Race to End Women’s Cancer for 3rd Year	GL
29/10/18	TESARO Announces Achievement of ZEJULA Prostate Cancer Development Milestones by Janssen	GL
24/10/18	TESARO and Actress Cobie Smulders Launch Not on My Watch, a National Movement to Empower the Ovarian Cancer Community	GL
09/10/18	TESARO Announces Data Presentations at the ESMO 2018 Congress	GL
02/10/18	TESARO Announces Data Presentations at the SITC 2018 Annual Meeting	GL
19/09/18	TESARO Announces Participation at Two Investor Conferences	GL
27/08/18	TESARO Announces Participation at Three Investor Conferences	GL
02/07/18	TESARO Partners With the Pan-Mass Challenge for 2018 Ride Benefiting Dana-Farber Cancer Institute	GL
05/06/18	TESARO Summarizes TOPACIO and QUADRA Trial Results Presented at 2018 ASCO Annual Meeting	GL
01/06/18	TESARO : Announces Addition of ZEJULA to Cancer Drugs Fund in UK	GL
01/06/18	TESARO Announces Addition of ZEJULA to Cancer Drugs Fund in UK	GL
16/05/18	TESARO Announces Presentations of Abstracts at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting	GL
08/05/18	TESARO : PSYCHOLOGICAL EFFECTS OF OVARIAN CANCER OFTEN OVERLOOKED, BUT CAN HAVE A SIGNIFICANT IMPACT ON PATIENTS – NEW EUROPEAN LITERATURE REVIEW REVEALS	PU
08/05/18	TESARO : Psychological Effects of Ovarian Cancer Often Overlooked and Can Have a Significant Impact on Patients	GL
03/05/18	TESARO Announces First-Quarter 2018 Operating Results	GL
01/05/18	TESARO Announces Participation in Two Investor Conferences	GL
24/04/18	TESARO Announces Positive Top-Line Results From Quadra Trial of ZEJULA®	GL
11/04/18	TESARO : and Medison Enter Into Exclusive Distribution Agreement to Commercialize ZEJULA® in Israel	GL
11/04/18	TESARO and Medison Enter Into Exclusive Distribution Agreement to Commercialize ZEJULA® in Israel	GL